Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Non-Small-Cell Lung Cancer (NSCLC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05738317
What this trial is testing

Adebrelimab Combined With Bevacizumab and Albumin Paclitaxel in Non-squamous NSCLC After First-line Treatment

Who this might be right for
Non-small Cell Lung Cancer
Xiaorong Dong 45
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05859217
What this trial is testing

Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC (Cabatezo-1)

Who this might be right for
Lung CancerNSCLC Stage IVMetastatic NSCLC - Non-Small Cell Lung Cancer+1 more
Jun Zhang, MD, PhD 40
Large-scale testing (Phase 3)Study completedNCT03802240
What this trial is testing

Sintilimab ± IBI305 Plus Chemotherapy (Pemetrexed + Cisplatin) for EGFRm + Locally Advanced or Metastasis Non-Squamous NSCLC Patients After EGFR-TKI Treatment Failure

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Innovent Biologics (Suzhou) Co. Ltd. 492
Testing effectiveness (Phase 2)UnknownNCT00003090
What this trial is testing

Biological Therapy in Previously Treated Patients With Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Cancer Biotherapy Research Group 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06885840
What this trial is testing

Study of MCLA-129 in the Treatment of Advanced Non-small Cell Lung Cancer with AGA and MET Amplification.

Who this might be right for
Non-Small Cell Lung Cancer
Betta Pharmaceuticals Co., Ltd. 100
Large-scale testing (Phase 3)Study completedNCT02504489
What this trial is testing

Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
BeyondSpring Pharmaceuticals Inc. 559
Testing effectiveness (Phase 2)UnknownNCT00997724
What this trial is testing

Assisted-VATS Sleeve Lobectomy for Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
The First Affiliated Hospital of Guangzhou Medical University 100
Large-scale testing (Phase 3)Active Not RecruitingNCT03793179
What this trial is testing

Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer

Who this might be right for
Lung Non-Squamous Non-Small Cell CarcinomaStage IIIB Lung Cancer AJCC v8Stage IIIC Lung Cancer AJCC v8+1 more
National Cancer Institute (NCI) 600
Not applicableLooking for participantsNCT05990946
What this trial is testing

Smartphone-based Remote Symptom Monitoring to Improve Postoperative Rehabilitation Exercise Adherence After Video-assisted Thoracic Surgery (VATS) for Lung Cancer

Who this might be right for
Lung Neoplasms, Non-Small Cell Lung CancerPostoperative ComplicationsPatient Reported Outcome Measures+2 more
Zhongshan People's Hospital, Guangdong, China 736
Large-scale testing (Phase 3)Active Not RecruitingNCT06632327
What this trial is testing

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Who this might be right for
Resectable Lung Non-Small Cell CarcinomaStage II Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8+1 more
Alliance for Clinical Trials in Oncology 37
Early research (Phase 1)Looking for participantsNCT05107674
What this trial is testing

NX-1607 in Adults With Advanced Malignancies

Who this might be right for
Ovarian Cancer, EpithelialGastric CancerGastroEsophageal Junction (GEJ) Cancer+11 more
Nurix Therapeutics, Inc. 345
Early research (Phase 1)Looking for participantsNCT05401110
What this trial is testing

Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung CancerLung Cancer
Karen Reckamp, MD, MS 60
Early research (Phase 1)Looking for participantsNCT05492682
What this trial is testing

START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer

Who this might be right for
Melanoma (Skin)Triple-Negative Breast CancerNon-Small Cell Lung Cancer+5 more
Valo Therapeutics Oy 15
Not applicableStudy completedNCT03948724
What this trial is testing

Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology

Who this might be right for
Therapeutic Patient EducationImmune Checkpoint InhibitorsMelanoma+4 more
Institut Cancerologie de l'Ouest 412
Not applicableUnknownNCT03424980
What this trial is testing

Evaluate Effectiveness and Safety of Tyrosine Kinase Inhibitors

Who this might be right for
Non-small Cell Lung Cancer Metastatic
Tang-Du Hospital 200
Testing effectiveness (Phase 2)Study completedNCT01498562
What this trial is testing

Phase II Study of Gefitinib Plus Nimotuzumab Versus Gefitinib in Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer (NSCLC)
Yonsei University 160
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07746388
What this trial is testing

Adaptive Chemotherapy for Pd-l1 High REsEctablE NSCLC: A Chemo-PHREE Trial

Who this might be right for
NsclcNSCLC Stage IINSCLC, Stage III+2 more
University of Maryland, Baltimore 30
Early research (Phase 1)Ended earlyNCT02199886
What this trial is testing

Dose-escalation Study of BIBH 1 in Patients With Non-small Cell Lung Cancer Scheduled for Surgical Resection

Who this might be right for
Lung Neoplasms
Boehringer Ingelheim 6
Early research (Phase 1)Study completedNCT03538028
What this trial is testing

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

Who this might be right for
Cervical CancerMicrosatellite Instability (MSI)-High Endometrial CancerGastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])+14 more
Incyte Biosciences International Sàrl 22
Not applicableUnknownNCT04858828
What this trial is testing

Investigation on Predictive Molecular Markers of Efficacy for Front-line Immunochemotherapy in Advanced NSCLC

Who this might be right for
Biomarkers
Zhou Chengzhi 200
Next Page